Alphatec Holdings (ATEC) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.43% |
| Dec 31, 2025 | -37.46% |
| Sep 30, 2025 | 7.40% |
| Jun 30, 2025 | 4.78% |
| Mar 31, 2025 | -38.70% |
| Dec 31, 2024 | -18.38% |
| Sep 30, 2024 | -15.14% |
| Jun 30, 2024 | 3.86% |
| Mar 31, 2024 | 32.34% |
| Dec 31, 2023 | 34.76% |
| Sep 30, 2023 | -30.77% |
| Jun 30, 2023 | -24.00% |
| Mar 31, 2023 | -30.94% |
| Dec 31, 2022 | -5.39% |
| Sep 30, 2022 | 9.02% |
| Jun 30, 2022 | 18.98% |
| Mar 31, 2022 | 28.41% |
| Dec 31, 2021 | 31.58% |
| Sep 30, 2021 | 37.56% |
| Jun 30, 2021 | 45.87% |
| Mar 31, 2021 | 35.44% |
| Dec 31, 2020 | 40.89% |
| Sep 30, 2020 | 18.21% |
| Jun 30, 2020 | -32.43% |
| Mar 31, 2020 | -27.23% |
| Dec 31, 2019 | -21.77% |
| Sep 30, 2019 | -17.77% |
| Jun 30, 2019 | -38.72% |
| Mar 31, 2019 | -43.88% |
| Dec 31, 2018 | -36.61% |
| Sep 30, 2018 | -36.20% |
| Jun 30, 2018 | -33.81% |
| Mar 31, 2018 | -33.34% |
| Dec 31, 2017 | -16.09% |
| Sep 30, 2017 | -16.44% |
| Mar 31, 2017 | -16.18% |
| Dec 31, 2016 | -16.75% |
| Sep 30, 2016 | -16.47% |
| Jun 30, 2016 | -16.74% |
| Dec 31, 2015 | -16.41% |